AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CAP nanotechnology product developments reported.
2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BPA) announced an update on recent developments of its calcium phosphate-based nanotechnology (CAP).
"To date we have made significant progress in development of our proprietary CAP nanotechnology," said Stephen M. Simes, BioSante's president and chief executive officer. "Currently, CAP nanotechnology is being developed for two lead uses, namely safer and more effective vaccines and therapeutic drug delivery, primarily proteins. We are product-focused and determined to continue to make progress in all areas."
To date, the following has been accomplished regarding development of CAP nanotechnology:
Product clinical and preclinical developments:
1) Phase I human clinical study completed, showing safety of injected CAP.
2) Positive results in several animal models using CAP as a safer vaccine adjuvant to improve the efficacy of vaccines versus no adjuvant and versus alum, ...
- European patent allowance granted for CAP nanotechnology.
- Newspaper article from: Vaccine Weekly May 19, 2004 700+ words
...property protection of our exclusive CAP nanotechnology. CAP continues to demonstrate both...medical applications." BioSante's CAP nanotechnology consists of microscopic particles...trial. This article was prepared by Vaccine Weekly editors from staff and other reports...
- BioSante Announces CAP Nanotechnology Product Development and Business Update.
- Press release article from: Business Wire February 2, 2004 700+ words
...in development of our proprietary CAP nanotechnology," said Stephen M. Simes, BioSante...executive officer. "Currently, CAP nanotechnology is being developed for two lead uses...accomplished regarding development of CAP nanotechnology: -- Product clinical and pre...
- BioSante Pharmaceuticals Announces Notice of Allowance For CAP Nanotechnology...
- Press release article from: Business Wire April 20, 2004 700+ words
...the intellectual property protection of our exclusive CAP nanotechnology. CAP continues to demonstrate both its potential as a...and therapeutic medical applications." BioSante's CAP nanotechnology consists of microscopic particles of calcium phosphate...
- BioSante Pharmaceuticals Announces Expansion of Patent Portfolio for CAP...
- Press release article from: Business Wire November 29, 2004 700+ words
...the intellectual property protection of our exclusive CAP nanotechnology," said Stephen M. Simes, president and chief executive...of non-injected biodefense vaccines." BioSante's CAP nanotechnology consists of microscopic particles of specially formulated...
- BioSante Pharmaceuticals Presents CaP Nanotechnology Review at International...
- Press release article from: Business Wire May 18, 2005 700+ words
...www.meetingsmanagement.com/imv_2005/. About BioVant Formulated using BioSante's proprietary CaP nanotechnology, BioVant is being tested as an adjuvant for orally and intranasally administered anthrax vaccines, among other...
- Positive results reported on CAP adjuvant study in CDC collaboration.
- Newspaper article from: Vaccine Weekly May 26, 2004 700+ words
...demonstrated its calcium phosphate (CAP) nanotechnology-based vaccine adjuvant, BioVant...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- BioSante Announces CaP Manufacturing Agreement and Progress in Protein Delivery.
- Press release article from: Business Wire May 3, 2005 700+ words
...significant progress with our proprietary CaP nanotechnology," said Stephen M. Simes, BioSante...must undergo daily injections." About CaP Nanotechnology CaP nanotechnology is being developed for two primary uses...
- BioSante Pharmaceuticals Reports Product Development Highlights and Financial...
- Press release article from: Business Wire March 31, 2006 700+ words
...stage hormone therapy products and CAP nanotechnology," commented Stephen M. Simes...the baby boom generation." "Our CaP nanotechnology continues to generate significant...important role for these women. CaP Nanotechnology Achievements --We signed a Material...
Source: HighBeam Research, CAP nanotechnology product developments reported.